The Alzheimer’s disease drug development landscape

Hosted by: Julius Clinical. Speakers: Pieter van Bokhoven | CSO| IAO Amsterdam Neuroscience AUMC Jort Vijverberg | Neurologist | Amsterdam Neuroscience AUMC Topics that are discussed during this webinar: All major trends in Alzh...

Speakers: Dr. Jort Vijverberg

Innovative Endpoints in Alzheimer’s Disease Clinical Trials

Together with our partner Brain Research Center, we presented the webinar:  Innovative Endpoints in Alzheimer’s Disease Clinical trials. During this webinar, two experts in the field, Dr. Niels Prins and Dr. Jort Vijverberg discussed the ...

Speakers: Dr. Jort Vijverberg
  • Webinars
  • CNS Diseases, Cardio-Metabolic Diseases, Infectious Diseases & Vaccines, ALS, Alzheimer's, Epilepsy, Hearing Loss, RSV, Vaccines, NASH, Real-World Evidence

A new area of outsourcing: Improve efficiency and streamline trail solutions with a personalized approach to clinical trial solution

Personalization is the new king of global outsourcing. Patients are crying out for more flexible, more diverse and less burdensome trial designs, while the ever larger CROs become less versatile with every merger. It’s no surprise that pharma is...

Download

"*" indicates required fields

*
*

Request for proposal

"*" indicates required fields

*
*
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn